NasdaqCM - Delayed Quote USD
BioLineRx Ltd. (BLRX)
3.6400
+0.4300
+(13.40%)
At close: May 20 at 4:00:01 PM EDT
3.4100
-0.23
(-6.32%)
After hours: May 20 at 7:44:57 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| Low Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| High Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| Year Ago EPS | -- | -- | -4.14 | -3.17 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 2 |
| Avg. Estimate | 1.48M | 1.83M | 5.83M | 7.27M |
| Low Estimate | 792k | 924k | 2.26M | 6.86M |
| High Estimate | 2.17M | 2.73M | 11.4M | 7.69M |
| Year Ago Sales | 6.86M | 5.39M | 28.94M | 5.83M |
| Sales Growth (year/est) | -78.40% | -66.12% | -79.86% | 24.82% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -11.6 | -5.6 | -4.4 | 0 |
| EPS Actual | 0 | 0 | 0 | -- |
| Difference | 11.6 | 5.6 | 4.4 | -- |
| Surprise % | 100.00% | 100.00% | 100.00% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| 7 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 30 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 60 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 90 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLRX | -- | -- | 23.43% | 82.33% |
| S&P 500 | 13.32% | 2.69% | 7.77% | 13.75% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 4/2/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/29/2024 |
Related Tickers
CANF Can-Fite BioPharma Ltd.
1.0550
+0.96%
PLX Protalix BioTherapeutics, Inc.
1.7200
+2.38%
OGEN Oragenics, Inc.
0.2020
+1.61%
CLRB Cellectar Biosciences, Inc.
0.2640
+3.33%
PLUR Pluri Inc.
4.8732
-1.55%
EVGN Evogene Ltd.
1.2700
-7.97%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.3000
-2.26%
KZR Kezar Life Sciences, Inc.
4.1100
+1.99%
ENTX Entera Bio Ltd.
2.0600
+2.49%
NRSN NeuroSense Therapeutics Ltd.
1.6300
+18.12%